STATE STREET CORP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$2,317,000
+41.5%
501,532
+7.1%
0.00%
Q4 2018$1,638,000
-66.8%
468,121
-4.3%
0.00%
Q3 2018$4,929,000
+54.5%
489,030
+10.9%
0.00%
Q2 2018$3,190,000
+17.7%
440,816
-1.8%
0.00%
Q1 2018$2,710,000
-38.1%
448,681
-1.4%
0.00%
Q4 2017$4,379,000
+3.9%
455,221
-4.0%
0.00%
Q3 2017$4,214,000
-29.4%
474,181
+0.6%
0.00%
-100.0%
Q2 2017$5,966,000
+24.6%
471,514
+3.4%
0.00%
Q1 2017$4,789,000
+16.0%
455,944
+1.6%
0.00%
Q4 2016$4,128,000
-71.6%
448,589
-63.6%
0.00%
-100.0%
Q3 2016$14,541,000
+7.5%
1,233,320
+17.9%
0.00%0.0%
Q2 2016$13,530,000
-41.5%
1,045,847
-27.7%
0.00%
-66.7%
Q1 2016$23,138,000
-32.8%
1,446,823
+20.4%
0.00%
-25.0%
Q4 2015$34,409,000
+15.6%
1,201,824
+14.9%
0.00%
+33.3%
Q3 2015$29,775,000
-23.2%
1,046,083
-3.1%
0.00%
-25.0%
Q2 2015$38,787,000
+30.4%
1,079,615
+111.0%
0.00%
+33.3%
Q1 2015$29,742,000
+454.4%
511,634
+301.8%
0.00%
+200.0%
Q4 2014$5,365,000
+12.9%
127,332
+4.0%
0.00%0.0%
Q3 2014$4,750,000
+38.8%
122,486
+11.9%
0.00%
Q2 2014$3,421,000
-39.3%
109,466
-19.6%
0.00%
-100.0%
Q1 2014$5,636,000
+74.4%
136,094
+63.1%
0.00%
Q4 2013$3,231,000
+74.8%
83,463
+57.8%
0.00%
Q3 2013$1,848,00052,9010.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders